Comparing biomarkers in regular cannabis users vs. non-users
Part of Mental health clinical trials.
This study compares biological markers between people who use cannabis regularly and those who do not, to understand how cannabis affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You smoke cannabis (with or without tobacco) at least once a week.
- You are between 18 and 65 years old.
- You have a valid driver's license for categories A, B, A1, B1, F, G, or M.
- You understand German well enough for the study procedures.
- You must not have used cannabis or nicotine on the study day, and no alcohol in the last 24 hours.
- You have no current or past major psychiatric disorder (like depression or schizophrenia), and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how cannabis and tobacco—used together or separately—affect your thinking speed, how you feel, and body responses. You may help researchers understand these effects under controlled conditions, which could be useful for safer use and treatment decisions.
This study looks at how smoked cannabis changes driving performance when compared across two age groups. It may help researchers understand safety risks and differences by age.
This study tests how vaporized cannabis and alcohol together affect your ability to drive or perform tasks. It is for healthy adults who have used both substances before.
This study looks at how high-potency cannabis concentrates affect people who already use cannabis a few times a week. You will be asked to vape a concentrate and then have your reactions monitored.
This early-phase study looks at how smoking cannabis affects your lungs and breath. Researchers will check your breath for signs of inflammation and other changes, which may help understand how cannabis affects lung health.
This early (Phase 1) study tests how an oral THC and CBD product affects the body in healthy adults who use cannabis only rarely. It may help researchers understand safety and effects before larger studies.
Hear when a new Driving Under the Influence of Cannabis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.